Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGuIX Nanoparticles + Stereotactic Radiation for Oligo Brain Metastases
NCT04094077Phase 2Terminated
- Sponsor
- Centre Léon Bérard
- Start
- Jan 2020
- Primary completion
- Feb 2021
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of AGuIX in brain metastases, sponsored by Centre Léon Bérard. Started Jan 2020; status: terminated.
02
Drugs
AGuIX
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT04094077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094077.